Start with the correction
The Cyprus IP Box allows a company to deduct 80% of the qualifying profit from an eligible intangible asset. Only the remaining 20% is taxed at the corporate rate. That mechanism is unchanged, and the 2026 tax reform left it entirely alone — it was not abolished, reduced or restricted.
But the corporate rate itself rose from 12.5% to 15% on 1 January. Twenty per cent of income taxed at 12.5% gave 2.5%. Twenty per cent taxed at 15% gives 3.0%. The regime is half a percentage point less generous than it was, and the great majority of published guides — including several from firms who should know better — still print the old figure.
Three per cent is still, by some distance, the most competitive IP regime in the European Union. Ireland's Knowledge Development Box sits at 6.25%, the Netherlands innovation box at 9%. The correction matters not because it changes the decision, but because a page still quoting 2.5% has not been reviewed since last year — and you should be asking what else on it is out of date.
The fraction that actually sets your rate
Three per cent is the ceiling, not the default. Cyprus adopted the OECD's modified nexus approach under BEPS Action 5, which ties the benefit to R&D you genuinely performed. The deduction applies only to a portion of your IP income, and that portion is set by a formula:
Qualifying expenditure is R&D your Cyprus company carried out itself — developer salaries, materials, overheads — plus R&D outsourced to unrelated third parties. This is the detail most founders get wrong in their favour: paying a freelance team in Poland or India is qualifying expenditure. Overall expenditure adds the cost of acquiring the IP and any R&D outsourced to related parties — your own group companies.
The 30% uplift is the OECD's deliberate softener: it lets a company that outsourced some work to a group entity still reach a full fraction, provided the bulk of the development was genuinely its own. But buy a finished asset from your parent company, do little further work on it, and the fraction collapses — and the headline rate becomes irrelevant.
| Your situation | Nexus fraction | Tax payable | Effective rate |
|---|---|---|---|
| All R&D in-house, or with unrelated contractors | 100% | €30,000 | 3.0% |
| Mostly in-house, with a small IP acquisition | 97.5% | €33,000 | 3.3% |
| Half the R&D outsourced to a group company | 65% | €72,000 | 7.2% |
| IP bought from the parent, little further development | 8.7% | €139,600 | 14.0% |
Illustrative, assuming the full €1,000,000 derives from a single qualifying asset and non-qualifying income is taxed at 15%. Real cases turn on per-asset expenditure records. Your accountant computes the actual fraction; this table exists to show how wide the spread is.
What qualifies
- Copyrighted softwareSaaS platforms, applications, algorithms and proprietary code developed in-house
- PatentsGranted patents and applications in progress
- Utility modelsAnd other legally protected, non-obvious and useful intangibles
- Exclusive licencesOver qualifying patents, where obtained from an unrelated party
- The income itselfRoyalties, licence fees, embedded IP income, and gains on disposal
What does not
- Trademarks and brandsExcluded by design — the OECD nexus approach targets R&D, not marketing
- Image rights, goodwill, customer listsAll marketing intangibles are outside the regime
- Trivial softwareA lightly customised open-source project is not a novel asset; expect to evidence the innovation
- IP parked, not builtAcquired from a related party with no meaningful subsequent R&D in Cyprus
Where it fits with everything else
The IP Box is one layer of a structure, not a strategy on its own. Profit from qualifying IP is taxed at roughly 3% inside the Cyprus company. What remains flows to you as dividends — and if you hold non-dom status, defence contribution on those dividends is zero, leaving only the capped health levy of roughly €4,770 a year. Your own tax residency can be established with sixty days of presence.
Put together, a founder whose income is genuinely IP-derived can see an all-in burden in the low single digits from company profit to personal pocket — legitimately, inside an OECD-sanctioned and EU-state-aid-compliant regime. Two further details worth knowing: gains on the disposal of qualifying IP are not taxable where the disposal is capital in nature, and the regime stacks with the Notional Interest Deduction on new equity, which can reduce the effective rate further.
There is no application form, no advance ruling and no registration. The deduction is claimed on the annual corporate tax return, prepared by your ICPAC-registered auditor — which sounds simple and is precisely why people get it wrong.
The mistake that costs the most
It is not choosing the wrong structure. It is failing to keep per-asset expenditure records from day one. The nexus fraction is calculated separately for each intangible asset, annually, and it depends on being able to show what was spent, by whom, on what, and whether the counterparty was related. Companies that begin tracking in year three cannot reconstruct year one — and the benefit they lose is permanent.
The other recurring error is assumption. Founders read "2.5% in Cyprus," move their holding company, and discover the fraction they actually qualify for is a third of what they imagined because the IP came from the group. That conversation should happen before the restructure, not after the first tax return — and it is exactly the kind of sequencing question I exist to catch.
Framework: Cyprus Income Tax Law Article 9B, as amended in October 2016 to implement OECD BEPS Action 5; corporate rate 15% from 1 January 2026 under the 2026 tax reform. Effective rates stated are for qualifying income after the nexus calculation. Rates, definitions and their interpretation change, and every IP structure turns on its specific facts. This article is general information, not legal or tax advice — the nexus fraction, transfer pricing documentation and the annual return are matters for a licensed Cyprus tax advisor and an ICPAC-registered auditor, whom I coordinate.